Introduction
============

The aim of this study was to compare the IGS 2 score with a predictive model built using clinical characteristics and biomarkers associated with 1-year mortality from procalcitonin, C-reactive protein, troponin I (TnI) and NT-Pro-BNP.

Methods
=======

We conducted a prospective observational cohort study in a polyvalent ICU. We calculated the IGS 2 severity score in the first 24 hours. We dosed NT-Pro-BNP, TnI, procalcitonin and C-reactive protein at admission to the ICU. To test the biomarker model, the patient database was divided into training (70%) and test (30%) databases. A neural network model was trained from variables associated with 1-year mortality. All statistics were done using R v.2.15.1. We used the pROC package to plot and compare ROC curves.

Results
=======

Lower age, NT-Pro-BNP and TnI were significantly associated with 1-year survival. We built a neural network model using the training database. We used the test database to compare our model with the IGS 2 score. The difference between the AUC of the biomarker score and the IGS 2 score was statistically significant (Figure [1](#F1){ref-type="fig"}).
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Conclusion
==========

Our new neural network model built using age, NT-PRO-BNP and TnI succeeded the internal-validation processes and predicts 1-year mortality better than IGS 2.
